Skip to main content
Equibles

STATE STREET CORP

Position in EDSA — Edesa Biotech, Inc.

CIK 93751 BOSTON, MA
Back to EDSA Full portfolio

Position in EDSA

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$308,769
+$110,139 QoQ
Shares Held
37,979
0.0% QoQ
Ownership
0.394%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 33 holders
Holding Since
Sep 2021
12 quarters on record
Voting authority Sole 65% Shared 0% None 35%

Common Shares in EDSA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. EDSA ranks #320 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in EDSA

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $308,769 37,979
2026-03-31 $198,630 37,979
2025-12-31 $26,524 18,679
2023-09-30 $27,704 43,975
2023-06-30 $35,619 43,975
2023-03-31 $40,017 43,975
2022-12-31 $94,986 43,975
2022-09-30 $22,241 24,175
2022-06-30 $38,921 24,175
2022-03-31 $67,938 22,875
2021-12-31 $128,786 22,875
2021-09-30 $102,397 13,875